Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03613623 · ClinicalTrials.gov registry record
Acromegaly: Patient And Physician Perspectives
A clinical trial, sponsored by Tulane University.
- Completed
- Registry status
- 152
- Enrollment target
NCT03613623 is a clinical trial that has completed, run by Tulane University. The registered enrollment target is 152 participants.
The verdict
NCT03613623 has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- 152 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the experiences of individuals with acromegaly who are receiving injections as part of their treatment regimen. Another objective of the study is to compare the patients' perception with their doctors' perceptions. The answers are important to help researchers and physicians understand what it is really like to take currently available treatments so that they can make efforts to improve patients' healthcare experiences, reduce treatment burden and, ultimately, improve patient's quality of life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2018-07-02 |
| Est. Completion | 2020-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03613623
The ClinicalTrials.gov registry entry for NCT03613623 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03613623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03613623 about?
NCT03613623 is a clinical study titled "Acromegaly: Patient And Physician Perspectives". The purpose of the study is to assess the experiences of individuals with acromegaly who are receiving injections as part of their treatment regimen. Another objective of the study is to compare the patients' perception with their doctors' perceptions. The answers are important to help researchers a...
What is the current status of trial NCT03613623?
This trial is currently completed. The enrollment target is 152 participants. The study started on 2018-07-02. Estimated completion is 2020-09-01.
Who is sponsoring clinical trial NCT03613623?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.